The pathogenic agent in Drosophila models of 'polyglutamine' diseases
- PMID: 15757976
- DOI: 10.1093/hmg/ddi096
The pathogenic agent in Drosophila models of 'polyglutamine' diseases
Abstract
A substantial body of evidence supports the identity of polyglutamine as the pathogenic agent in a variety of human neurodegenerative disorders where the mutation is an expanded CAG repeat. However, in apparent contradiction to this, there are several human neurodegenerative diseases (some of which are clinically indistinguishable from the 'polyglutamine' diseases) that are due to expanded repeats that cannot encode polyglutamine. As polyglutamine cannot be the pathogenic agent in these diseases, either the different disorders have distinct pathogenic pathways or some other common agent is toxic in all of the expanded repeat diseases. Recently, evidence has been presented in support of RNA as the pathogenic agent in Fragile X-associated tremor/ataxia syndrome (FXTAS), caused by expanded CGG repeats at the FRAXA locus. A Drosophila model of FXTAS, in which 90 copies of the CGG repeat are expressed in an untranslated region of RNA, exhibits both neurodegeneration and similar molecular pathology to the 'polyglutamine' diseases. We have, therefore, explored the identity of the pathogenic agent, and specifically the role of RNA, in a Drosophila model of the polyglutamine diseases by the expression of various repeat constructs. These include expanded CAA and CAG repeats and an untranslated CAG repeat. Our data support the identity of polyglutamine as the pathogenic agent in the Drosophila models of expanded CAG repeat neurodegenerative diseases.
Similar articles
-
Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases.Hum Mol Genet. 2011 Oct 1;20(19):3757-68. doi: 10.1093/hmg/ddr292. Epub 2011 Jun 30. Hum Mol Genet. 2011. PMID: 21724553
-
Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease.Hum Mol Genet. 2012 Feb 1;21(3):536-47. doi: 10.1093/hmg/ddr487. Epub 2011 Oct 21. Hum Mol Genet. 2012. PMID: 22021427
-
Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat.Hum Mol Genet. 2007 Oct 1;16(19):2326-32. doi: 10.1093/hmg/ddm186. Epub 2007 Jul 17. Hum Mol Genet. 2007. PMID: 17635840
-
[Molecular biology of polyglutamine diseases].Postepy Hig Med Dosw. 2002;56(6):779-88. Postepy Hig Med Dosw. 2002. PMID: 12661407 Review. Polish.
-
Trinucleotide repeats and neurodegenerative disease.Brain. 2004 Nov;127(Pt 11):2385-405. doi: 10.1093/brain/awh278. Epub 2004 Aug 25. Brain. 2004. PMID: 15329351 Review.
Cited by
-
Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14995-5000. doi: 10.1073/pnas.1308535110. Epub 2013 Aug 26. Proc Natl Acad Sci U S A. 2013. PMID: 23980182 Free PMC article.
-
Long tract of untranslated CAG repeats is deleterious in transgenic mice.PLoS One. 2011 Jan 21;6(1):e16417. doi: 10.1371/journal.pone.0016417. PLoS One. 2011. PMID: 21283659 Free PMC article.
-
RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis.Front Cell Neurosci. 2014 Dec 19;8:431. doi: 10.3389/fncel.2014.00431. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25565965 Free PMC article. Review.
-
Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.Mol Hum Reprod. 2016 Jun;22(6):384-96. doi: 10.1093/molehr/gaw023. Epub 2016 Mar 9. Mol Hum Reprod. 2016. PMID: 26965313 Free PMC article.
-
Ubiquitous expression of CUG or CAG trinucleotide repeat RNA causes common morphological defects in a Drosophila model of RNA-mediated pathology.PLoS One. 2012;7(6):e38516. doi: 10.1371/journal.pone.0038516. Epub 2012 Jun 8. PLoS One. 2012. PMID: 22715390 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials